NCT07407985 2026-02-12
GK01IIT-TZ03
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Active not recruiting
Clinical Trials
44 trialsNCT07351903 2026-01-20
GUARDIAN-02
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Recruiting
NCT06066424 2025-10-14
Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT02498912 2025-07-31
Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Active not recruiting
NCT05231733 2024-10-31
Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors
SparX Biotech(Jiangsu) Co., Ltd.
Phase 1 Withdrawn
NCT06553846 2024-08-14
A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors
Fudan University
Phase 1 Not yet recruiting
NCT01379287 2023-02-02
Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02435927 2021-04-28
ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin
National Cancer Centre, Singapore
Phase 1 Unknown
NCT00613847 2020-10-26
Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02078349 2020-09-10
Phase I Study of KPT330 in Asian Patients
National University Hospital, Singapore
Phase 1 Completed
NCT01548924 2020-04-17
Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors
Centro Nacional de Investigaciones Oncologicas CARLOS III
Phase 1 Terminated
NCT02058901 2019-07-17
Study of High-dose, Intermittent Sunitinib in Patients With Solid Tumors.
Amsterdam UMC, location VUmc
Phase 1 Completed
NCT02250781 2019-05-22
Oral ONC201 in Treating Patients With Advanced Solid Tumors
Rutgers, The State University of New Jersey
Phase 1 Completed
NCT02845414 2018-10-03
Study of CD133KDEL Toxin in the Treatment for Solid Tumors
Masonic Cancer Center, University of Minnesota
Phase 1 Withdrawn
NCT02439489 2018-06-20
Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors
Fondazione Michelangelo
Phase 1 Completed
NCT02296879 2018-01-17
A Multicenter, Open Label, Phase I Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous SAIT301 in Subjects With Advanced c-MET Positive (+) Solid Tumors Followed by Expansion in Selected Tumor Types
Samsung Medical Center
Phase 1 Completed
NCT01485042 2017-09-01
PATH
Duke University
Phase 1 Completed
NCT00776867 2017-08-01
Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00186979 2017-04-26
Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors
St. Jude Children's Research Hospital
Phase 1 Completed
NCT01297452 2017-03-31
BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02353026 2016-11-18
Phase I Study of Intravenous Artesunate for Solid Tumors
Georgetown University
Phase 1 Completed
NCT01349296 2016-05-20
BARIS
University of Cologne
Phase 1 Completed
NCT00554268 2016-02-19
Trial of PBI-05204 in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Completed
NCT02395068 2015-08-19
Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors
Biotech Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT00770263 2015-06-03
Erlotinib and Temsirolimus for Solid Tumors
Washington University School of Medicine
Phase 1 Completed
NCT00888043 2015-03-11
CNTO95/Avastin
Duke University
Phase 1 Completed
NCT00984425 2014-12-02
The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors
Istituto Clinico Humanitas
Phase 1 Completed
NCT00586443 2014-11-19
BEP
Duke University
Phase 1 Completed
NCT01702129 2014-09-09
Anti-EGFR Immunoliposomes in Solid Tumors
University Hospital, Basel, Switzerland
Phase 1 Completed
NCT00720148 2014-08-26
A Phase I Trial of Bortezomib and Sunitinib
Emory University
Phase 1 Completed
NCT00550199 2013-08-19
LBH589 and Gemcitabine in the Treatment of Solid Tumors
SCRI Development Innovations, LLC
Phase 1 Terminated
NCT00869388 2013-07-15
A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors
Washington University School of Medicine
Phase 1 Completed
NCT00586092 2013-04-08
A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors
Duke University
Phase 1 Completed
NCT01800812 2013-02-28
OM-174
Centre Hospitalier Universitaire Dijon
Phase 1 Completed
NCT00500422 2013-02-13
Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00697502 2012-11-01
Study of Capecitabine In Patients With Solid Tumors
National University Hospital, Singapore
Phase 1 Completed
NCT00495872 2012-10-18
Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00502892 2012-08-01
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00509782 2012-08-01
Phase I Trial of ZIO-101 in Patients With Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00586560 2012-05-15
KTN10010
Baylor College of Medicine
Phase 1 Completed
NCT01072890 2012-03-28
Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors
University of California, Davis
Phase 1 Completed
NCT00556088 2010-12-30
LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors
SCRI Development Innovations, LLC
Phase 1 Completed
NCT00863733 2009-03-18
DMXAA
Cancer Research UK
Phase 1 Completed
NCT00165373 2007-12-28
rhEndostatin Protein Involving Pediatric Patients With Cancer
Dana-Farber Cancer Institute
Phase 1 Terminated